Study D3250C00059: A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK)

Project: Other project

StatusActive
Effective start/end date8/19/198/18/21

Funding

  • AstraZeneca LP: $8,773.08